NCT05375292 Evaluation of the Impact of Prehabilitation on Recovery Following Open Surgery for Abdominal Aortic Aneurysm
| NCT ID | NCT05375292 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Toulouse |
| Condition | Abdominal Aortic Aneurysm |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2022-12-06 |
| Primary Completion | 2025-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2022-12-06 with a primary completion date of 2025-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a pilot, prospective, randomized control trial that aim to provide a first estimation of the 3-month post-operative variation in the functional recovery of patients who benefited from an outpatient pre-habilitation program and patients who did not benefit from it.
Eligibility Criteria
Inclusion Criteria: * Patient with an abdominal aortic aneurysm (Thoraco-abdominal aneurysm type 4/Supra renal/Juxta-renal/Sub renal) treated with conventional surgery. * Surgical indication of aneurysm by size (50-55mm) Exclusion Criteria: \- Patient requiring urgent management that does not allow for a pre-authorisation protocol of at least 6 weeks.
Contact & Investigator
Aurélien Hostalrich, MD
PRINCIPAL INVESTIGATOR
University Hospital, Toulouse
Frequently Asked Questions
Who can join the NCT05375292 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Abdominal Aortic Aneurysm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05375292 currently recruiting?
Yes, NCT05375292 is actively recruiting participants. Contact the research team at hostalrich.a@chu-toulouse.fr for enrollment information.
Where is the NCT05375292 trial being conducted?
This trial is being conducted at Toulouse, France.
Who is sponsoring the NCT05375292 clinical trial?
NCT05375292 is sponsored by University Hospital, Toulouse. The principal investigator is Aurélien Hostalrich, MD at University Hospital, Toulouse. The trial plans to enroll 60 participants.